Cargando…

Antibiotic Therapy for Pulmonary Exacerbations in Cystic Fibrosis—A Single-Centre Prospective Observational Study

People with cystic fibrosis experience bronchopulmonary exacerbations, leading to lung damage, lung function decline, increased mortality, and a poor health-related quality of life. To date, there are still open questions regarding the rationale for antibiotic use and the optimal duration of antibio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwarz, Carsten, Wimmer, Eliana, Holz, Frederik, Grehn, Claudia, Staab, Doris, Eschenhagen, Patience Ndidi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135273/ https://www.ncbi.nlm.nih.gov/pubmed/37107096 http://dx.doi.org/10.3390/antibiotics12040734

Ejemplares similares

Prospective Evaluation of Aspergillus fumigatus-Specific IgG in Patients With Cystic Fibrosis
por: Eschenhagen, Patience, et al.
Publicado: (2021)

Frequent Pet Contact as Risk Factor for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis
por: Grehn, Claudia, et al.
Publicado: (2021)

Hypersensitivity to parenteral antibiotics in patients with cystic fibrosis
por: Roehmel, Jobst, et al.
Publicado: (2014)

Proliferative activity of antigen-specific CD154+ T cells against bacterial and fungal respiratory pathogens in cystic fibrosis decreases after initiation of highly effective CFTR modulator therapy
por: Eschenhagen, Patience N., et al.
Publicado: (2023)

Genetic diversification of persistent Mycobacterium abscessus within cystic fibrosis patients
por: Lewin, Astrid, et al.
Publicado: (2021)

Risk factors for respiratory Aspergillus fumigatus in German Cystic Fibrosis patients and impact on lung function
por: Düesberg, Uta, et al.
Publicado: (2020)

Urban Life as Risk Factor for Aspergillosis
por: Grehn, Claudia, et al.
Publicado: (2020)

Impact of Long-Term Tiotropium Bromide Therapy on Annual Lung Function Decline in Adult Patients with Cystic Fibrosis
por: Brandt, Claudia, et al.
Publicado: (2016)

Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis()
por: Hoppe, Jordana E., et al.
Publicado: (2018)

Hemoglobin Oxygen Affinity in Patients with Cystic Fibrosis
por: Böning, Dieter, et al.
Publicado: (2014)

Aetiological agents for pulmonary exacerbations in children with cystic fibrosis: An observational study from a tertiary care centre in northern India
por: Arvind, Balaji, et al.
Publicado: (2020)

Home intravenous antibiotic treatment for acute pulmonary exacerbations in cystic fibrosis — Is it good for the patient?
por: Sequeiros, Iara Maria, et al.
Publicado: (2009)

Prospective multicenter German study on pulmonary colonization with Scedosporium /Lomentospora species in cystic fibrosis: Epidemiology and new association factors
por: Schwarz, Carsten, et al.
Publicado: (2017)

Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations
por: Merjaneh, Lina, et al.
Publicado: (2020)

Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations
por: VanDevanter, Donald R, et al.
Publicado: (2010)

Measuring the impact of an empiric antibiotic algorithm for pulmonary exacerbation in children and young adults with cystic fibrosis
por: Kennedy, Charles, et al.
Publicado: (2022)

Staff costs of hospital-based outpatient care of patients with cystic fibrosis
por: Hollmeyer, Helge, et al.
Publicado: (2011)

Neutrophil Elastase Enhances Sputum Solubilization in Cystic Fibrosis Patients Receiving DNase Therapy
por: Papayannopoulos, Venizelos, et al.
Publicado: (2011)

Antigen specificity and cross-reactivity drive functionally diverse anti–Aspergillus fumigatus T cell responses in cystic fibrosis
por: Schwarz, Carsten, et al.
Publicado: (2023)

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
por: Sawant, Akhil, et al.
Publicado: (2018)

Evaluation of Copeptin during Pulmonary Exacerbation in Cystic Fibrosis
por: Wojsyk-Banaszak, I., et al.
Publicado: (2019)

Lung ultrasound for the diagnosis of cystic fibrosis pulmonary exacerbation
por: Hassanzad, Maryam, et al.
Publicado: (2021)

Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study
por: Grosse-Onnebrink, Joerg, et al.
Publicado: (2017)

Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score
por: Mainz, Jochen G., et al.
Publicado: (2022)

Impact of exacerbations of cystic fibrosis on muscle strength
por: Burtin, Chris, et al.
Publicado: (2013)

Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score
por: Mainz, Jochen G., et al.
Publicado: (2023)

Glucose Tolerance during Pulmonary Exacerbations in Children with Cystic Fibrosis
por: Widger, John, et al.
Publicado: (2012)

Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis
por: DiMango, Emily, et al.
Publicado: (2014)

Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
por: Zemanick, Edith T., et al.
Publicado: (2013)

Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations
por: Skolnik, Kate, et al.
Publicado: (2018)

Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis
por: Asner, Sandra, et al.
Publicado: (2012)

Health-related quality of life in children with cystic fibrosis: validation of the German CFQ-R
por: Schmidt, Anne, et al.
Publicado: (2009)

Pulmonary Exacerbations in Adults With Cystic Fibrosis: A Grown-up Issue in a Changing Cystic Fibrosis Landscape
por: Stanford, Gemma E., et al.
Publicado: (2021)

European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis Centre
por: Conway, Steven, et al.
Publicado: (2014)

BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
por: Schultz, Andre, et al.
Publicado: (2023)

Lung ultrasound assessment of response to antibiotic therapy in cystic fibrosis exacerbations: a study of two cases
por: Peixoto, Andressa Oliveira, et al.
Publicado: (2019)

Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease
por: Quinn, Robert A., et al.
Publicado: (2016)

The renoprotective effect of concomitant fosfomycin in the treatment of pulmonary exacerbations in cystic fibrosis
por: Al-Aloul, Mohamed, et al.
Publicado: (2019)

Clinical impact of respiratory virus in pulmonary exacerbations of children with Cystic Fibrosis
por: Meyer, Viviane Mauro Correa, et al.
Publicado: (2020)

Azithromycin and Tobramycin Therapy in Cystic Fibrosis Pulmonary Exacerbations: Less Is More?
por: Thornton, Christina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g6fj7h06dbaf7smku43e6pblnf